Teal Venture Partners Lead Trials.ai Pre-Seed Round
Retrieved on:
Friday, November 15, 2019
Teal Venturesselected Trials.ai as the fourth company in its Fund I portfolio, joining 19Labs, Mobile Medical Office, and Neuralace.
Key Points:
- Teal Venturesselected Trials.ai as the fourth company in its Fund I portfolio, joining 19Labs, Mobile Medical Office, and Neuralace.
- In addition to Teal Ventures, new and existing investors include Amplify LA, Sway Ventures and Nex Cubed.
- At Teal Venture Partners, entrepreneurs are our lifeblood.
- Our Partners are startup founders and CEOs with more than 75 years combined experience in healthcare investing and operations.